Flu vaccines recalled

Two batches of flu vaccine are recalled by manufacturer Novartis, following a request by the UK's medicines watchdog.

The MHRA said there was no need to revaccinate people who have received the vaccine being recalled
The MHRA said there was no need to revaccinate people who have received the vaccine being recalled

The MHRA asked the company to undertake a 'precautionary recall' of two batches of Agrippal vaccine, but stressed there was no evidence of safety concerns.

The recall came after visible 'protein aggregates' were detected in one batch for the Italian market during a routine inspection by Novartis. The company said it had availability to replace all recalled doses.

An MHRA statement said: 'At the request of MHRA, Novartis Vaccines and Diagnostics is executing a precautionary recall of the above batches.

'Based on the information available, there is no evidence of any new safety concerns or of any impact on efficacy. No adverse reactions which may be associated with this issue have been reported to Novartis in connection with these batches.'

The MHRA said there was no need to revaccinate people who have received flu vaccine from these batches. Remaining stocks should be quarantined and returned to the original supplier, it said.

A spokeswoman for Novartis said: 'During a routine pre-release quality analysis of one batch of Agrippal for the Italian market, Novartis identified visible protein aggregates in one batch of vaccines which was not released to the market.

'The protein aggregates are not uncommon in vaccines and have no impact on their safety or efficacy. Individuals already vaccinated with Agrippal in the UK should not be concerned and there is no need for revaccination.'

The affected batch numbers are 126201A and 126102. Both contain pack sizes of 10 pre-filled syringes with the expiry date of 31 May 2013, and were first distributed on 9 and 17 October 2012 respectively.

The recall comes after manufacturer Crucell voluntarily halted deliveries of two batches of flu vaccine to the UK in October on patient safety grounds.

Have you registered with us yet?

Register now to enjoy more articles and free email bulletins

Register

Already registered?

Sign in

Follow Us:

Just published

Communication failures 'stopping GPs doing their jobs', PCN leaders warn

Communication failures 'stopping GPs doing their jobs', PCN leaders warn

'Poorly executed' communications from NHS and government officials are preventing...

Oxford COVID vaccine is up to 90% effective, latest data reveal

Oxford COVID vaccine is up to 90% effective, latest data reveal

The COVID-19 vaccine developed by the University of Oxford has been shown to be 70.4%...

GPs expect major COVID vaccination role as soon as first doses are ready

GPs expect major COVID vaccination role as soon as first doses are ready

GPs are expecting to be heavily involved in delivering COVID-19 vaccination in England...

GP phone lines 'jammed' as flu jab expansion comes without warning

GP phone lines 'jammed' as flu jab expansion comes without warning

Practices have reported phone lines being 'jammed' with a deluge of calls from patients...

Scottish GPs to play 'key role' in COVID vaccine programme run by health boards

Scottish GPs to play 'key role' in COVID vaccine programme run by health boards

GPs in Scotland are to play a 'key role' in a COVID-19 vaccination programme expected...

Pandemic offers one-off chance to reform NHS culture and retain doctors, says GMC chair

Pandemic offers one-off chance to reform NHS culture and retain doctors, says GMC chair

The COVID-19 pandemic is a one-off opportunity to create a more compassionate work...